Home » Stocks » BMY » Financials » Balance Sheet

Bristol-Myers Squibb Company (BMY)

Stock Price: $66.47 USD -0.30 (-0.45%)
Updated Jun 18, 2021 4:00 PM EDT - Market closed

Balance Sheet (Annual)

Numbers in millions USD. Fiscal year is January - December.
Year202020192018201720162015201420132012201120102009200820072006
Cash & Equivalents14,54612,3466,9115,4214,2372,3855,5713,5861,6565,7765,0337,6837,9761,8012,018
Short-Term Investments1,2853,0471,8481,3912,1131,8851,8649391,1732,9572,2688312894241,995
Cash & Cash Equivalents15,83115,3938,7596,8126,3504,2707,4354,5252,8298,7337,3018,5148,2652,2254,013
Cash Growth2.85%75.74%28.58%7.28%48.71%-42.57%64.31%59.95%-67.61%19.61%-14.25%3.01%271.46%-44.56%-
Receivables8,5017,6855,7476,3005,5434,2993,3903,3603,0833,7433,4803,1643,6443,9943,247
Inventory2,0744,2931,1951,1661,2411,2211,5601,4981,6571,3841,2041,4131,7652,1622,079
Other Current Assets3,7861,9832,0155765706252,2239,5331,9521,4581,2888671,0231,721963
Total Current Assets30,19229,35417,71614,85413,70410,41514,60818,9169,52115,31813,27313,95814,69710,10210,302
Property, Plant & Equipment5,8866,2525,0275,0014,9804,4124,4174,5795,3334,5214,6645,0555,4055,6505,673
Long-Term Investments4337671,7752,4802,7194,6604,4083,7473,5232,9092,6811,369188--
Goodwill and Intangibles73,79086,4577,6298,0738,2608,3008,7809,41416,4138,7108,6038,0835,9786,3286,681
Other Long-Term Assets8,1807,1142,8393,1434,0443,9611,5361,9361,1071,5121,8552,5433,2183,8462,919
Total Long-Term Assets88,289100,59017,27018,69720,00321,33319,14119,67626,37617,65217,80317,05014,78915,82415,273
Total Assets118,481129,94434,98633,55133,70731,74833,74938,59235,89732,97031,07631,00829,48625,92625,575
Accounts Payable2,7132,4451,8922,2481,6641,5652,4872,5592,2022,6031,9831,7111,5351,4421,239
Deferred Revenue---5371,3091,5891,9371,5254,8491,2031,2971,1861,068915765
Current Debt2,3403,3461,7039879921395903598261151172311541,891187
Other Current Liabilities14,02712,5137,0595,7914,8764,7243,4477,9974023,8593,3423,1853,9534,1504,305
Total Current Liabilities19,08018,30410,6549,5638,8418,0178,46112,4408,2797,7806,7396,3136,7108,3986,496
Long-Term Debt48,33643,3875,6466,9755,7166,5507,2427,9816,5685,3765,3286,1306,5854,3817,248
Other Long-Term Liabilities13,18316,5554,5595,1662,8032,7573,0632,9357,4123,9473,3713,7803,9832,5851,840
Total Long-Term Liabilities61,51959,94210,20512,1418,5199,30710,30510,91613,9809,3238,6999,91010,5686,9669,088
Total Liabilities80,59978,24620,85921,70417,36017,32418,76623,35622,25917,10315,43816,22317,27815,36415,584
Total Debt50,67646,7337,3497,9626,7086,6897,8328,3407,3945,4915,4456,3616,7396,2727,435
Debt Growth8.44%535.91%-7.7%18.69%0.28%-14.59%-6.09%12.79%34.66%0.84%-14.4%-5.61%7.45%-15.64%-
Common Stock18,38018,644-17,272-17,130-14,833-14,879-15,264-15,657-15,908-14,068-13,552-13,376-7,589-7,739-8,209
Retained Earnings21,28134,47434,06531,16033,51331,61332,54132,95232,73333,06931,63630,76022,54919,76219,845
Comprehensive Income-1,839-1,520-2,762-2,289-2,503-2,468-2,425-2,141-3,202-3,045-2,371-2,541-2,719-1,461-1,645
Shareholders' Equity37,82251,59814,03111,74116,17714,26614,85215,15413,62315,95615,71314,84312,24110,5629,991
Total Liabilities and Equity118,421129,84434,89033,44533,53731,59033,61838,51035,88233,05931,15131,06629,51925,92625,575
Net Cash / Debt-34,845-31,3401,410-1,150-358-2,419-397-3,815-4,5653,2421,8562,1531,526-4,047-3,422
Net Cash / Debt Growth11.18%--221.23%-85.20%509.32%-89.59%-16.43%-74.68%-13.79%41.09%-18.26%-
Net Cash Per Share-15.42-19.240.86-0.70-0.21-1.45-0.24-2.32-2.771.911.081.090.77-2.05-1.75
Working Capital11,11211,0507,0625,2914,8632,3986,1476,4761,2427,5386,5347,6457,9871,7043,806
Book Value Per Share16.7431.678.607.179.688.558.959.208.259.429.187.496.195.365.10

Showing 15 of 30 years

15 more years are available